Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
D136754-50mg | 50mg | In stock | $77.90 | |
D136754-100mg | 100mg | In stock | $122.90 | |
D136754-250mg | 250mg | In stock | $276.90 | |
D136754-1g | 1g | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $996.90 | |
D136754-5g | 5g | In stock | $4,483.90 |
Prolyl hydroxylase (PHD) inhibitor
Synonyms | DMOG|89464-63-1|dimethyloxalylglycine|DIMETHYLOXALOYLGLYCINE|Dimethyloxallyl glycine|methyl 2-((2-methoxy-2-oxoethyl)amino)-2-oxoacetate|dimethyloxaloylglycine (dmog)|Dimethyloxaloylglycine(DMOG)|methyl 2-[(2-methoxy-2-oxoethyl)amino]-2-oxoacetate|N-(2-Me |
---|---|
Specifications & Purity | ≥98%(HPLC) |
Biochemical and Physiological Mechanisms | DMOG is a cell permeable prolyl-4-hydroxylase inhibitor, which upregulates HIF (hypoxia-inducible factor). The protein level of HIF-1α subunit is post-transcriptionally regulated by prolyl and asparaginyl hydroxylase (PAH). Suppression of PAH activity inc |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Refer to SDS for further information Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Product Description | Dimethyloxallyl Glycine(DMOG) is a cell permeable, competitive inhibitor of HIF-PH(HIF-1α prolyl hydroxylase). |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Pubchem Sid | 488190296 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488190296 |
IUPAC Name | methyl 2-[(2-methoxy-2-oxoethyl)amino]-2-oxoacetate |
INCHI | InChI=1S/C6H9NO5/c1-11-4(8)3-7-5(9)6(10)12-2/h3H2,1-2H3,(H,7,9) |
InChi Key | BNJOZDZCRHCODO-UHFFFAOYSA-N |
Canonical SMILES | COC(=O)CNC(=O)C(=O)OC |
Isomeric SMILES | COC(=O)CNC(=O)C(=O)OC |
WGK Germany | 3 |
PubChem CID | 560326 |
Molecular Weight | 175.14 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
A2206724 | Certificate of Analysis | Oct 08, 2023 | D136754 |
A2206732 | Certificate of Analysis | Oct 08, 2023 | D136754 |
A2206781 | Certificate of Analysis | Oct 08, 2023 | D136754 |
G2120320 | Certificate of Analysis | May 10, 2023 | D136754 |
G2117215 | Certificate of Analysis | May 09, 2023 | D136754 |
G2120319 | Certificate of Analysis | May 09, 2023 | D136754 |
A2416034 | Certificate of Analysis | Nov 09, 2022 | D136754 |
B2303297 | Certificate of Analysis | Nov 09, 2022 | D136754 |
B2303304 | Certificate of Analysis | Nov 09, 2022 | D136754 |
B2303305 | Certificate of Analysis | Nov 09, 2022 | D136754 |
B2303306 | Certificate of Analysis | Nov 09, 2022 | D136754 |
B2303307 | Certificate of Analysis | Nov 09, 2022 | D136754 |
B2303308 | Certificate of Analysis | Nov 09, 2022 | D136754 |
B2303310 | Certificate of Analysis | Nov 09, 2022 | D136754 |
Solubility | Soluble in water at 30mg/ml. |
---|---|
Boil Point(°C) | 182 °C/12 mmHg |
Melt Point(°C) | 51 °C |
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H302:Harmful if swallowed |
Precautionary Statements | P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P270:Do not eat, drink or smoke when using this product. P330:Rinse mouth. P301+P317:IF SWALLOWED: Get medical help. |
WGK Germany | 3 |
1. Magdaleno C et al.. (2020) HIFa independent mechanisms in renal carcinoma cells modulate divergent outcomes in fibronectin assembly mediated by hypoxia and CoCl2.. Sci Rep, 10 (18560). [PMID:33122751] |
2. Cluff E et al.. (2022) Hypoxia-inducible factor-1 alpha expression is induced by IL-2 via the PI3K/mTOR pathway in hypoxic NK cells and supports effector functions in NKL cells and ex vivo expanded NK cells.. Cancer Immunol Immunother, [PMID:34999917] |